Key player · Company profile
AstraZeneca
Named as a key player in 396 of our reports, across 33 regions and countries.
Named as a key player in 396 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 12
Brazil 12
Canada 12
China 12
Ecuador 12
Egypt 12
France 12
Germany 12
Hong Kong 12
India 12
Italy 12
Japan 12
Kenya 12
Malaysia 12
Mexico 12
New Zealand 12
Philippines 12
Russia 12
Saudi Arabia 12
Singapore 12
South Africa 12
Spain 12
Thailand 12
UAE 12
UK 12
US 12| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Oncology/Cancer Drugs | Pharmaceuticals | $177 Bn | 8.4% |
| Asthma & COPD Drugs | Pharmaceuticals | $49.5 Bn | 4% |
| Over The Counter (OTC) Vitamins and Minerals | OTC & Nutraceuticals | $32 Bn | 5.5% |
| Over The Counter (OTC) Analgesics | OTC & Nutraceuticals | $22 Bn | 3.4% |
| Anti-Depressants Drugs | Pharmaceuticals | $18 Bn | 2.7% |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | OTC & Nutraceuticals | $14.5 Bn | 4.1% |
| Over The Counter (OTC) Gastrointestinal Drugs | OTC & Nutraceuticals | $5.6 Bn | 3.9% |
| Over The Counter (OTC) Sleep Aid Products | OTC & Nutraceuticals | $5.3 Bn | 4% |
| Alexipharmic Drugs | Pharmaceuticals | – | – |
| Alopecia areata | Healthcare Services | – | – |
| Antithrombotic Drugs | Pharmaceuticals | – | – |
| Atherosclerosis Drugs | Pharmaceuticals | – | – |
Named as key players in the same markets as AstraZeneca (number of shared markets).
Johnson & Johnson8 shared markets
Merck & Co., Inc.8 shared markets
Novartis AG8 shared markets
Sanofi8 shared markets
Pfizer Inc.7 shared markets
Bristol-Myers Squibb Company5 shared markets
GSK PLC5 shared markets
AbbVie Inc.3 shared markets